Catherine T Milne1, Armann O Ciccarelli2, Mandie Lassy. 1. Connecticut Clinical Nursing Associates, LLC and Bristol Hospital Wound, Ostomy, Lymphedema Center, Bristol, Connecticut; Email: ccna2@juno.com. 2.
Abstract
UNLABELLED: Comparisons of collagenase to other methods of debridement, including wet to dry dressings, have been reported in the literature; however, studies comparing collagenase to hydrogel have not been reported. OBJECTIVE: Time to complete necrotic tissue debridement with collagenase compared to hydrogel in institutionalized adults with pressure ulcers. METHODS: Randomization occurred after obtaining informed consent to avoid selection bias. Subjects received daily dressing changes with either hydrogel or collagenase followed by a standard semi-occlusive dressing to evaluate time to debridement up to Day 42. Investigators, who were blinded to randomization, evaluated weekly wound photographs for necrotic tissue debridement and wound healing parameters using a digital planimetry software package. Nonviable tissue was not cross-hatched in either group. RESULTS:Twenty-seven nursing home residents were enrolled over a period of 1 year. According to a Student's t test, there were no significant differences between groups for age, gender, age of wound, or percentage of nonviable tissue at the time of enrollment (P = .03). Using a Pearson Chi square analysis, the collagenase group was found to have statistical (P = .003) significance in achieving full debridement by Day 42. CONCLUSION: This study showed statistical significance in favor of collagenase when used to debride nonviable tissue in pressure ulcers. Despite recommendations to cross-hatch eschar, statistical significance was still achieved when wounds were not cross-hatched, indicating clinical utility in settings without clinician availability for the cross-hatching procedure.
RCT Entities:
UNLABELLED: Comparisons of collagenase to other methods of debridement, including wet to dry dressings, have been reported in the literature; however, studies comparing collagenase to hydrogel have not been reported. OBJECTIVE: Time to complete necrotic tissue debridement with collagenase compared to hydrogel in institutionalized adults with pressure ulcers. METHODS: Randomization occurred after obtaining informed consent to avoid selection bias. Subjects received daily dressing changes with either hydrogel or collagenase followed by a standard semi-occlusive dressing to evaluate time to debridement up to Day 42. Investigators, who were blinded to randomization, evaluated weekly wound photographs for necrotic tissue debridement and wound healing parameters using a digital planimetry software package. Nonviable tissue was not cross-hatched in either group. RESULTS: Twenty-seven nursing home residents were enrolled over a period of 1 year. According to a Student's t test, there were no significant differences between groups for age, gender, age of wound, or percentage of nonviable tissue at the time of enrollment (P = .03). Using a Pearson Chi square analysis, the collagenase group was found to have statistical (P = .003) significance in achieving full debridement by Day 42. CONCLUSION: This study showed statistical significance in favor of collagenase when used to debride nonviable tissue in pressure ulcers. Despite recommendations to cross-hatch eschar, statistical significance was still achieved when wounds were not cross-hatched, indicating clinical utility in settings without clinician availability for the cross-hatching procedure.
Authors: Charles Chidiebele Maduba; Ugochukwu Uzodimma Nnadozie; Victor Ifeanyichukwu Modekwe; Victoria Maduba; Gabriel Maduwuike Okorie; Valentine Okechukwu Onyebum Journal: World J Plast Surg Date: 2022-03
Authors: Adrienne M Gilligan; Curtis R Waycaster; Richard Bizier; Bong-Chul Chu; Marissa J Carter; Caroline E Fife Journal: Adv Wound Care (New Rochelle) Date: 2017-04-01 Impact factor: 4.730
Authors: Travis A Motley; Adrienne M Gilligan; Darrell L Lange; Curtis R Waycaster; Jaime E Dickerson Journal: J Foot Ankle Res Date: 2015-02-28 Impact factor: 2.303
Authors: Elizabeth S Mearns; Michael Liang; Brendan L Limone; Adrienne M Gilligan; Jeffrey D Miller; Kathleen D Schaum; Curtis R Waycaster Journal: Clinicoecon Outcomes Res Date: 2017-08-16